StonvexLoading…
StonvexStonvexStonvexCore line items from SNA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-03 | Annual 2024 2024-12-28 | Annual 2023 2023-12-30 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $4.71B | $4.68B | $4.70B | $4.47B |
Operating Income | $1.33B | $1.35B | $1.31B | $1.21B |
Net Income | $1.02B | $1.04B | $1.01B | $911.70M |
EPS (Diluted) | $19.19 | $19.51 | $18.76 | $16.82 |
Total Assets | $8.41B | $7.90B | $7.54B | $6.97B |
Total Liabilities | $2.46B | $2.48B | $2.45B | $2.47B |
Cash & Equivalents | $1.62B | $1.36B | $1.00B | $757.20M |
Free Cash Flow OCF − CapEx | $1.01B | $1.13B | $1.06B | $591.00M |
Shares Outstanding | 53.00M | 53.50M | 53.90M | 54.20M |